Ambarella (AMBA) director granted 2,498 RSUs; holdings now 9,978 shares
Ambarella director Elizabeth M. Schwarting received an annual restricted stock unit (RSU) award of 2,498 ordinary shares approved by the board, reported as a transaction dated 09/02/2025.
Rhea-AI Filing Summary
Ambarella director Elizabeth M. Schwarting received an annual restricted stock unit (RSU) award of 2,498 ordinary shares approved by the board, reported as a transaction dated 09/02/2025. The grant has a vesting schedule that vests one-fourth every three months beginning with a vesting start date of 09/15/2025 and becomes fully vested on 09/15/2026, subject to continued service. The Form 4 shows Schwarting beneficially owns 9,978 shares following the grant and the reported price for the award is listed as $0.0, consistent with an equity grant rather than a purchase.
Positive
- None.
Negative
- None.
Insights
TL;DR: Routine annual RSU grant to an independent director with standard service-based quarterly vesting over one year.
The board-approved award of 2,498 RSUs to Director Elizabeth Schwarting appears to be a standard compensation action for independent directors. The one-year cliff-to-full vesting schedule delivered in quarterly installments aligns director incentives with continued service through 09/15/2026. There is no indication in the filing of accelerated vesting, change-in-control provisions, or cash consideration; the grant is reported as $0.0 which is typical for RSU awards reflecting compensation rather than a market purchase. Impact on dilution or share count is not provided in this Form 4.
TL;DR: Non-market equity grant recorded for an insider; transaction is informational and has limited immediate market impact.
The Form 4 documents an equity compensation event dated 09/02/2025 where 2,498 RSUs were granted and will vest quarterly beginning 09/15/2025 through 09/15/2026. The report shows 9,978 shares beneficially owned after the grant. As a single director grant, the disclosure informs shareholders of insider holdings changes but does not, by itself, present material financial metrics such as aggregate dilution, expense recognition, or timing of share issuance. The filing does not disclose any sale, exercise, or cash transaction tied to these RSUs.
Insider Trade Summary
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Grant/Award | Ordinary Shares | 2,498 | $0.00 | $0.00 |
Footnotes (1)
- F1. Effective as of September 2, 2025, the Board of Directors approved an annual restricted stock unit grant of 2,498 Ordinary Shares to each independent director. The RSU grant vests as to 1/4th of the Ordinary Shares each three months following the vesting start date of September 15, 2025, so as to be 100% vested on September 15, 2026, subject to continued service with the Company.
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What did Elizabeth M. Schwarting report on Form 4 for AMBA?
When do the RSUs granted to the director vest?
Was there any cash paid for the RSU award in the Form 4?
Does the Form 4 disclose accelerated vesting or change-in-control terms for the RSUs?
AI-generated analysis. How Rhea-AI works. Not financial advice.